This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n6http://linked.opendata.cz/resource/domain/vavai/subjekt/
n5http://linked.opendata.cz/ontology/domain/vavai/
n12http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n14http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68081740%3A_____%2F11%3A00371948%21RIV13-AV0-68081740/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n15http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68081740%3A_____%2F11%3A00371948%21RIV13-AV0-68081740
rdf:type
n5:Vysledek skos:Concept
dcterms:description
The aim was to assess the time to first improvement associated with atypical (AAP) and typical (TAP) antipsychotic drugs in patients with early-onset schizophrenia. This study involved a chart review of all schizophrenic patients in our hospital, with selected AAPs and TAPs, between 1997 and 2007 (296 teenage patients, 141 males, 155 females; mean age 16 years). The time to first improvement could be estimated in 258 patients; of these, 195 patients treated with AAPs and 63 patients with TAPs. Most patients were taking risperidone (96), followed by olanzapine (64). The mean time to first improvement was 6,9 days in the AAP group and 5,8 days in the TAP group (p=0,063). The mean time to first improvement was 7,1 days for risperidone, 6,7 days for olanzapine, 6,5 for ziprasidone, 6,1 for quetiapine, 7,4 for clozapine, 5,2 for haloperidol, 5,9 for perphenazine, and 6,0 for sulpiride. Differences among drugs were not significant (p=0.680). The aim was to assess the time to first improvement associated with atypical (AAP) and typical (TAP) antipsychotic drugs in patients with early-onset schizophrenia. This study involved a chart review of all schizophrenic patients in our hospital, with selected AAPs and TAPs, between 1997 and 2007 (296 teenage patients, 141 males, 155 females; mean age 16 years). The time to first improvement could be estimated in 258 patients; of these, 195 patients treated with AAPs and 63 patients with TAPs. Most patients were taking risperidone (96), followed by olanzapine (64). The mean time to first improvement was 6,9 days in the AAP group and 5,8 days in the TAP group (p=0,063). The mean time to first improvement was 7,1 days for risperidone, 6,7 days for olanzapine, 6,5 for ziprasidone, 6,1 for quetiapine, 7,4 for clozapine, 5,2 for haloperidol, 5,9 for perphenazine, and 6,0 for sulpiride. Differences among drugs were not significant (p=0.680).
dcterms:title
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses
skos:prefLabel
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses
skos:notation
RIV/68081740:_____/11:00371948!RIV13-AV0-68081740
n5:predkladatel
n6:ico%3A68081740
n3:aktivita
n17:I n17:Z
n3:aktivity
I, Z(AV0Z70250504), Z(MSM0021620849)
n3:cisloPeriodika
5
n3:dodaniDat
n15:2013
n3:domaciTvurceVysledku
n11:9962387
n3:druhVysledku
n16:J
n3:duvernostUdaju
n4:S
n3:entitaPredkladatele
n14:predkladatel
n3:idSjednocenehoVysledku
218394
n3:idVysledku
RIV/68081740:_____/11:00371948
n3:jazykVysledku
n13:eng
n3:klicovaSlova
schizophrenia; antipsychotics; onset of action
n3:klicoveSlovo
n7:schizophrenia n7:antipsychotics n7:onset%20of%20action
n3:kodStatuVydavatele
SE - Švédské království
n3:kontrolniKodProRIV
[E491B96D940C]
n3:nazevZdroje
Neuroendocrinology Letters
n3:obor
n18:AN
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
4
n3:rokUplatneniVysledku
n15:2011
n3:svazekPeriodika
32
n3:tvurceVysledku
Dudová, I. Hrdlička, M. Zedková, I. Urbánek, Tomáš
n3:wos
000300543900015
n3:zamer
n12:MSM0021620849 n12:AV0Z70250504
s:issn
0172-780X
s:numberOfPages
4